Skip to main content

Advertisement

SpringerLink
Log in

Clinical usefulness of AGEs as a biomarker for the attenuation of NASH

  • Letter to the Editor
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kimura Y, Hyogo H, Yamagishi SI, Takeuchi M, Ishitobi T, Nabeshima Y, et al. Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH. J Gastroenterol. 2010. doi:10.1007/s00535-010-0203-y.

  2. Tanaka Y, Uchino H, Shimizu T, Yoshii H, Niwa M, Ohmura C, et al. Effect of metformin on advanced glycation endproduct formation and peripheral nerve function in streptozotocin-induced diabetic rats. Eur J Pharmacol. 1999;376:17–22.

    Article  CAS  PubMed  Google Scholar 

  3. Beisswenger PJ, Howell SK, Touchette AD, Lal S, Szwergold BS. Metformin reduces systemic methylglyoxal levels in type 2 diabetes. Diabetes. 1999;48:198–202.

    Article  CAS  PubMed  Google Scholar 

  4. Komiya N, Hirose H, Saisho Y, Saito I, Itoh H. Effects of 12-month valsartan therapy on glycation and oxidative stress markers in type 2 diabetic subjects with hypertension. Int Heart J. 2008;49:681–9.

    Article  CAS  PubMed  Google Scholar 

  5. Nelson A, Torres DM, Morgan AE, Fincke C, Harrison SA. A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: a randomized placebo-controlled trial. J Clin Gastroenterol. 2009;43:990–4.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Gulhane School of Medicine, Ankara, Turkey

    Ilker Tasci

Authors
  1. Ilker Tasci
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ilker Tasci.

Additional information

An answer to this letter to the editor is available at doi:10.1007/s00535-010-0230-8.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tasci, I. Clinical usefulness of AGEs as a biomarker for the attenuation of NASH. J Gastroenterol 45, 779–780 (2010). https://doi.org/10.1007/s00535-010-0229-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-010-0229-1

Keywords

Search

Navigation